Evaluation of Age-Related Changes in Teneligliptin Pharmacokinetics in Japanese and European Descent Subjects Using a Physiologically Based Pharmacokinetic Model

被引:0
|
作者
Hiroaki Iijima
Hidetoshi Shimizu
Kazumi Mori-Anai
Atsuhiro Kawaguchi
Yoji Mochida
Toshimasa Yamauchi
Takashi Kadowaki
机构
[1] Mitsubishi Tanabe Pharma Corporation,Medical Affairs Department, Ikuyaku. Integrated Value Development Division
[2] Mitsubishi Tanabe Pharma Corporation,Data Science Department, Ikuyaku. Integrated Value Development Division
[3] Mitsubishi Tanabe Pharma Corporation,Medical Intelligence Department, Ikuyaku. Integrated Value Development Division
[4] The University of Tokyo,Department of Diabetes and Metabolic Diseases, Graduate School of Medicine
[5] Toranomon Hospital,undefined
来源
Diabetes Therapy | 2024年 / 15卷
关键词
DPP-4 inhibitors; Older subjects; Pharmacokinetics; Physiologically based pharmacokinetic model; Simulation; Teneligliptin; Type 2 diabetes;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:763 / 777
页数:14
相关论文
共 50 条
  • [1] Evaluation of Age-Related Changes in Teneligliptin Pharmacokinetics in Japanese and European Descent Subjects Using a Physiologically Based Pharmacokinetic Model
    Iijima, Hiroaki
    Shimizu, Hidetoshi
    Mori-Anai, Kazumi
    Kawaguchi, Atsuhiro
    Mochida, Yoji
    Yamauchi, Toshimasa
    Kadowaki, Takashi
    [J]. DIABETES THERAPY, 2024, 15 (04) : 763 - 777
  • [2] Publisher Correction: Evaluation of Age-Related Changes in Teneligliptin Pharmacokinetics in Japanese and European Descent Subjects Using a Physiologically Based Pharmacokinetic Model
    Hiroaki Iijima
    Hidetoshi Shimizu
    Kazumi Mori-Anai
    Atsuhiro Kawaguchi
    Yoji Mochida
    Toshimasa Yamauchi
    Takashi Kadowaki
    [J]. Diabetes Therapy, 2024, 15 : 779 - 780
  • [3] Application of Physiologically Based Pharmacokinetic Modeling to Predict Pharmacokinetics in Healthy Japanese Subjects
    Matsumoto, Yuki
    Cabalu, Tamara
    Sandhu, Punam
    Hartmann, Georgy
    Iwasa, Takashi
    Yoshitsugu, Hiroyuki
    Gibson, Christopher
    Uemura, Naoto
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 105 (04) : 1018 - 1030
  • [4] Age-related changes in pharmacokinetics and pharmacodynamics of lerisetron in the rat: A population pharmacokinetic model
    Jauregizar, N
    Quintana, A
    Suarez, E
    Raczka, E
    de la Fuente, L
    Calvo, R
    [J]. GERONTOLOGY, 2003, 49 (04) : 205 - 214
  • [5] Evaluation of Age-Related Pyrethroid Pharmacokinetic Differences in Rats: Physiologically-Based Pharmacokinetic Model Development Using In Vitro Data and In Vitro to In Vivo Extrapolation
    Song, Gina
    Moreau, Marjory
    Efremenko, Alina
    Lake, Brian G.
    Wu, Huali
    Bruckner, James V.
    White, Catherine A.
    Osimitz, Thomas G.
    Creek, Moire R.
    Hinderliter, Paul M.
    Clewell, Harvey J.
    Yoon, Miyoung
    [J]. TOXICOLOGICAL SCIENCES, 2019, 169 (02) : 365 - 379
  • [6] Pharmacokinetics and safety of rilpivirine in healthy Japanese subjects and exploration of ethnic sensitivity of rilpivirine pharmacokinetics with physiologically based pharmacokinetic model approach
    Ohta, Kentaro
    Matsushima, Nobuko
    Tanii, Hiromi
    Crauwels, Herta
    Kudo, Toshiyuki
    Ito, Kiyomi
    [J]. DRUG METABOLISM AND PHARMACOKINETICS, 2021, 41
  • [7] Modelling Age-Related Changes in the Pharmacokinetics of Risperidone and 9-Hydroxyrisperidone in Different CYP2D6 Phenotypes Using a Physiologically Based Pharmacokinetic Approach
    Kneller, Lisa Alina
    Hempel, Georg
    [J]. PHARMACEUTICAL RESEARCH, 2020, 37 (06)
  • [8] Modelling Age-Related Changes in the Pharmacokinetics of Risperidone and 9-Hydroxyrisperidone in Different CYP2D6 Phenotypes Using a Physiologically Based Pharmacokinetic Approach
    Lisa Alina Kneller
    Georg Hempel
    [J]. Pharmaceutical Research, 2020, 37
  • [9] Comparison and evaluation of pharmacokinetics of PFOA and PFOS in the adult rat using a physiologically based pharmacokinetic model
    Loccisano, Anne E.
    Campbell, Jerry L., Jr.
    Butenhoff, John L.
    Andersen, Melvin E.
    Clewell, Harvey J., III
    [J]. REPRODUCTIVE TOXICOLOGY, 2012, 33 (04) : 452 - 467
  • [10] EVALUATION OF PHYSIOLOGICALLY BASED PHARMACOKINETIC (PBPK) MODEL IN PREDICTING PHARMACOKINETICS (PK) OF DACOMITINIB AND METABOLITE IN HEALTHY CHINESE SUBJECTS.
    Liu, J.
    Saravanakumar, A.
    Lin, J.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 107 : S69 - S69